Mersana Therapeutics Inc

XNAS: MRSN

Weak Stock

Download real time

0.45 -0.03 (-6.25%)

New 52W Low in past week

1.8M XNAS Volume

XNAS 18 Mar, 2025 1:36 PM (EDT)

56.1

Market Cap

Below industry Median

-0.2

Beta 1Year

Very Low volatility

Mersana Therapeutics Inc - MRSN - stock price prediction, stock price target, analyst ratings from 10 analysts

Mersana Therapeutics Inc has a share price target of US$ 5, revenue growth forecast of -33.1%, and profit growth estimate of -44.7% for FY25, based on top 10 analyst calls.

Forecaster Screeners